Antioxidants: a possible role in kidney protection

Area of Science:

• Nephrology
• Oxidative Stress Research
• Pharmacology

Background:

• Oxidative stress is a key factor in kidney injury pathophysiology.
• Several beneficial medications for kidney disease, including ACE inhibitors and ARBs, mitigate oxidative stress.
• Antioxidants are explored for their potential to prevent and reduce kidney scarring.

Purpose of the Study:

• To review the role of oxidative stress in kidney injury.
• To evaluate the efficacy and safety of antioxidant therapies in kidney disease.
• To identify the need for further clinical trials on antioxidant strategies.

Main Methods:

• Review of existing literature on oxidative stress and kidney disease.
• Analysis of studies involving natural and synthetic antioxidants in animal models.
• Assessment of limited human studies on antioxidant supplementation.
• Evaluation of potential pro-oxidant effects of some antioxidants.

Main Results:

• Numerous antioxidants (e.g., vitamins, N-acetylcysteine, flavonoids) show benefits in animal models of kidney disease.
• Human studies are scarce, and evidence for recommending antioxidant supplements is insufficient.
• Certain antioxidant supplements may paradoxically exhibit pro-oxidant properties, potentially worsening kidney damage.

Conclusions:

• Current evidence does not support the routine use of antioxidant supplements in kidney disease patients.
• Therapeutic antioxidant strategies require rigorous investigation through prospective, controlled clinical trials.
• Further research is essential to determine the safety and effectiveness of antioxidants in renal protection.